Atlas Trials

A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection Fraction

Clinical trial NCT04840914 · COMPLETED

Trial details

NCT number
NCT04840914
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Heart Failure With Reduced Ejection Fraction
Start date
2021-06-01
Primary completion
2024-05-09
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.